# Coverage Reconciliation Report

**Generated:** 2026-01-31T23:54:47.273Z

## Summary

| Category | Count |
|----------|-------|
| Contradictions | 0 |
| New Coverage to Add | 25 |
| Confirmations | 0 |
| Not Covered | 9 |

## ⚠️ Contradictions

OpenOnco shows coverage, but payer policy says not covered.

_None found_

## ✚ New Coverage to Add

Payer policies show coverage not yet reflected in OpenOnco.

| Test | Payer | Position | Source |
|------|-------|----------|--------|
| Guardant360 CDx | Anthem BCBS | conditional | [Molecular Oncology (CG-GENE-14)](https://files.providernews.anthem.com/2003/CG-GENE-14.pdf) |
| Guardant360 CDx | Humana | conditional | [Liquid Biopsy](https://assets.humana.com/is/content/humana/Liquid_Biopsypdf) |
| Guardant360 CDx | EviCore | conditional | [Liquid Biopsy Testing (MOL.TS.194.A)](https://www.evicore.com/sites/default/files/clinical-guidelines/2025-12/MOL.TS_.194.A_Liquid%20Biopsy%20Testing_V1.0.2026_Eff01.01.2026_Pub09.26.2025_Upd12.09.2025.pdf) |
| Guardant360 CDx | Blue Shield of California | conditional | [Oncology: Algorithmic Testing](https://www.blueshieldca.com/content/dam/bsca/en/provider/docs/medical-policies/Oncology-Algorithmic-Testing.pdf) |
| FoundationOne Liquid CDx | Medicare | conditional | [Next Generation Sequencing (NCD 90.2)](https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=372) |
| FoundationOne Liquid CDx | Anthem BCBS | conditional | [Molecular Oncology (CG-GENE-14)](https://files.providernews.anthem.com/2003/CG-GENE-14.pdf) |
| FoundationOne Liquid CDx | Humana | conditional | [Liquid Biopsy](https://assets.humana.com/is/content/humana/Liquid_Biopsypdf) |
| FoundationOne Liquid CDx | EviCore | conditional | [Liquid Biopsy Testing (MOL.TS.194.A)](https://www.evicore.com/sites/default/files/clinical-guidelines/2025-12/MOL.TS_.194.A_Liquid%20Biopsy%20Testing_V1.0.2026_Eff01.01.2026_Pub09.26.2025_Upd12.09.2025.pdf) |
| FoundationOne Liquid CDx | Blue Shield of California | conditional | [Oncology: Algorithmic Testing](https://www.blueshieldca.com/content/dam/bsca/en/provider/docs/medical-policies/Oncology-Algorithmic-Testing.pdf) |
| clonoSEQ | Aetna | covered | [Tumor Markers (CPB 0352)](https://www.aetna.com/cpb/medical/data/300_399/0352.html) |
| FoundationOne CDx | Aetna | conditional | [Pharmacogenetic Testing (CPB 0715)](https://www.aetna.com/cpb/medical/data/700_799/0715.html) |
| FoundationOne CDx | Medicare | conditional | [Next Generation Sequencing (NCD 90.2)](https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=372) |
| FoundationOne CDx | Anthem BCBS | conditional | [Molecular Oncology (CG-GENE-14)](https://files.providernews.anthem.com/2003/CG-GENE-14.pdf) |
| FoundationOne CDx | Blue Shield of California | conditional | [Oncology: Algorithmic Testing](https://www.blueshieldca.com/content/dam/bsca/en/provider/docs/medical-policies/Oncology-Algorithmic-Testing.pdf) |
| BRACAnalysis CDx | Aetna | conditional | [Pharmacogenetic Testing (CPB 0715)](https://www.aetna.com/cpb/medical/data/700_799/0715.html) |
| FoundationOne Heme | Blue Shield of California | conditional | [Oncology: Algorithmic Testing](https://www.blueshieldca.com/content/dam/bsca/en/provider/docs/medical-policies/Oncology-Algorithmic-Testing.pdf) |
| Oncotype DX Breast Recurrence Score | Cigna | conditional | [Tumor Profiling (Policy 0520)](https://static.cigna.com/assets/chcp/pdf/coveragePolicies/medical/mm_0520_coveragepositioncriteria_tumor_profiling.pdf) |
| Oncotype DX Breast Recurrence Score | UnitedHealthcare | conditional | [Molecular Oncology Testing for Cancer](https://www.uhcprovider.com/content/dam/provider/docs/public/policies/comm-medical-drug/molecular-oncology-testing-for-cancer.pdf) |
| Oncotype DX Breast Recurrence Score | Blue Shield of California | conditional | [Oncology: Algorithmic Testing](https://www.blueshieldca.com/content/dam/bsca/en/provider/docs/medical-policies/Oncology-Algorithmic-Testing.pdf) |
| Guardant360 Response | EviCore | conditional | [Liquid Biopsy Testing (MOL.TS.194.A)](https://www.evicore.com/sites/default/files/clinical-guidelines/2025-12/MOL.TS_.194.A_Liquid%20Biopsy%20Testing_V1.0.2026_Eff01.01.2026_Pub09.26.2025_Upd12.09.2025.pdf) |
| Caris Assure | EviCore | conditional | [Liquid Biopsy Testing (MOL.TS.194.A)](https://www.evicore.com/sites/default/files/clinical-guidelines/2025-12/MOL.TS_.194.A_Liquid%20Biopsy%20Testing_V1.0.2026_Eff01.01.2026_Pub09.26.2025_Upd12.09.2025.pdf) |
| Tempus xF | Blue Shield of California | conditional | [Oncology: Algorithmic Testing](https://www.blueshieldca.com/content/dam/bsca/en/provider/docs/medical-policies/Oncology-Algorithmic-Testing.pdf) |
| IsoPSA | Blue Shield of California | conditional | [Oncology: Algorithmic Testing](https://www.blueshieldca.com/content/dam/bsca/en/provider/docs/medical-policies/Oncology-Algorithmic-Testing.pdf) |
| Tempus xT | Blue Shield of California | conditional | [Oncology: Algorithmic Testing](https://www.blueshieldca.com/content/dam/bsca/en/provider/docs/medical-policies/Oncology-Algorithmic-Testing.pdf) |
| Tempus xF+ | Blue Shield of California | conditional | [Oncology: Algorithmic Testing](https://www.blueshieldca.com/content/dam/bsca/en/provider/docs/medical-policies/Oncology-Algorithmic-Testing.pdf) |

## ✓ Confirmations

_None_

## ✗ Explicitly Not Covered

| Test | Payer | Source |
|------|-------|--------|
| Guardant360 CDx | Aetna | Pharmacogenetic Testing (CPB 0715) |
| FoundationOne Liquid CDx | Aetna | Pharmacogenetic Testing (CPB 0715) |
| Signatera | Humana | Liquid Biopsy |
| Shield | Anthem BCBS | Molecular Oncology (CG-GENE-14) |
| Guardant360 Response | Humana | Liquid Biopsy |
| HelioLiver | Humana | Liquid Biopsy |
| Galleri | Humana | Liquid Biopsy |
| Galleri | EviCore | Multi-Cancer Early Detection Screening (MOL.TS.396.A) |
| Galleri | BCBS Michigan | Circulating Tumor DNA |

---
*Generated by reconcile-coverage.js*